Stock listing

TWSE:1789 ScinoPharm Taiwan, Ltd. (神隆) 股價

Follow ScinoPharm Taiwan, Ltd. into a list and get an email when it puts out news.

Share price · TWSE:1789

$16.85 TWD -1.90 (-10.1%)

Close on Nov 20, 2026

Past year -1.2% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$16.85 – $18.00 TWDNov 20, 2026
Volume
1.35M sharesNov 20, 2026
Market cap
$13.32B TWDAt the close on Nov 20, 2026 · price × 790.7M shares outstanding
52-week range
$16.70 – $29.10 TWDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$10.69M TWDMedian day 422,591 shares · 1 day with no trades · last 3 months, Aug 20, 2026 – Nov 20, 2026
ScinoPharm Taiwan, Ltd. logo

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · TWSE:1789 · TWD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$16.85-1.90-10.1%$18.00$18.00$16.851,353,825
$18.75-0.40-2.1%$19.35$19.35$18.65570,608
$19.15-0.50-2.5%$19.60$19.80$19.00552,207
$19.65-0.05-0.3%$19.80$20.35$19.55834,424
$19.70+0.05+0.3%$19.65$20.05$19.50568,286
$19.65-0.35-1.8%$20.05$20.05$19.55754,788
$20.00-0.25-1.2%$20.20$20.20$19.75719,843
$20.25-0.60-2.9%$20.40$20.70$19.851,180,519
$20.85+0.70+3.5%$19.85$21.05$19.801,587,052
$20.15+0.70+3.6%$18.50$20.40$18.351,582,181
$19.45-0.45-2.3%$19.90$20.10$19.45622,433
$19.90+0.10+0.5%$19.80$20.15$19.40627,527
$19.80-0.50-2.5%$20.30$20.35$19.65809,041
$20.30+0.30+1.5%$20.10$20.30$19.95722,046
$20.00+0.10+0.5%$19.95$20.00$19.65525,008
$19.90-0.10-0.5%$20.00$20.25$19.90595,795
$20.00+0.25+1.3%$19.90$20.00$19.70764,609
$19.75+0.30+1.5%$19.60$19.80$19.50718,648
$19.450.000.0%$19.45$19.45$19.450
$19.45-0.15-0.8%$19.65$19.70$19.40353,027
$19.60+0.40+2.1%$19.35$19.70$19.35305,614
$19.20-0.10-0.5%$19.00$19.55$19.00378,943
$19.30-0.40-2.0%$19.80$19.80$19.30368,381
$19.70-0.10-0.5%$20.00$20.20$19.70699,966
$19.80-0.05-0.3%$19.80$20.40$19.60962,100
$19.85+0.45+2.3%$19.40$19.85$19.35425,181
$19.40-0.20-1.0%$19.35$19.60$19.15420,000
$19.60+0.50+2.6%$19.20$19.95$19.20814,040
$19.10+0.15+0.8%$18.95$19.40$18.90441,001
$18.95+0.30+1.6%$18.65$19.00$18.65325,837
$18.65+0.15+0.8%$18.65$18.80$18.55229,986
$18.50-0.10-0.5%$18.80$18.80$18.50344,085
$18.60-0.20-1.1%$18.80$18.80$18.45413,412
$18.80-0.15-0.8%$18.80$18.95$18.70276,036
$18.95+0.40+2.2%$18.70$19.10$18.65341,400
$18.55-0.05-0.3%$18.50$18.90$18.50177,044
$18.60-0.30-1.6%$18.90$18.90$18.55293,070
$18.90+0.05+0.3%$19.00$19.10$18.90182,073
$18.85-0.30-1.6%$19.15$19.15$18.85312,304
$19.15+0.15+0.8%$19.00$19.30$18.85361,117
$19.00-0.60-3.1%$19.40$19.40$18.801,035,060
$19.60+1.45+8.0%$18.20$19.85$18.201,627,240
$18.15+0.05+0.3%$18.15$18.25$18.10274,000
$18.10+0.10+0.6%$18.05$18.10$17.90312,040
$18.00-0.30-1.6%$18.15$18.15$18.00522,488
$18.30-0.30-1.6%$18.50$18.50$18.15841,216
$18.60-0.55-2.9%$18.95$19.00$18.55808,209
$19.150.000.0%$19.05$19.30$19.00257,050
$19.15-0.25-1.3%$19.30$19.50$19.15315,010
$19.40+0.30+1.6%$19.40$19.65$19.10550,593
$19.10+0.20+1.1%$19.00$19.15$18.90345,537
$18.90-0.10-0.5%$18.95$19.20$18.90414,200
$19.000.000.0%$19.00$19.10$18.80399,625
$19.000.000.0%$19.00$19.30$18.95363,340
$19.00-0.10-0.5%$18.95$19.35$18.90315,869
$19.10+0.05+0.3%$19.05$19.20$19.05155,504
$19.050.000.0%$18.95$19.20$18.95183,054
$19.05+0.10+0.5%$18.95$19.10$18.90274,105
$18.95-0.25-1.3%$19.10$19.10$18.95234,140
$19.20-0.25-1.3%$19.45$19.45$19.05222,776
$19.450.000.0%$19.45$19.55$19.15560,290
$19.45+0.50+2.6%$18.95$19.50$18.95699,244

Splits

4 splits since 2012 · TWSE:1789 · every price before a split is adjusted for it

DayRatioWhat
26-for-25Split
26-for-25Split
26-for-25Split
103-for-100Split
Ticker
TWSE:1789
Asset type
Stock
Sector
Health care
Industry
Pharmaceuticals
Exchange
TWSE
Currency
TWD

What changed lately

Latest news

All ScinoPharm Taiwan, Ltd. news

ScinoPharm Taiwan, Ltd. on 6ix

Sector
Health care
Industry
Pharmaceuticals
News releases
1 in the last 12 months · 5 in all · newest Jan 5, 2026 · oldest 2014
Decks
45 decks · latest Aug 2, 2018

Valuation

P/E 797× against a median of 27.3×: the highest of 8 Pharmaceuticals companies shown. Statements: 4 quarters to Sep 30, 2026 · balance Jun 30, 2026 · price Nov 20, 2026

Enterprise value
$10.70B TWD
P/E
797×
EV/sales
3.5×
EV/EBITDA
No depreciation figure on 6ix yet
Price/book
1.3×
Gross margin
27.5%
Operating margin
−3.7%
Net margin
0.5%
Debt to equity
0.1×
Beta
No index for this market yet

Pharmaceuticals: the 10 companies nearest in size, of 492 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
ScinoPharm Taiwan, Ltd. · TWSE:1789US$404.3MUS$324.6M797×3.5×n/a1.3×0.5%0.1×n/a
Zhejiang Chengyi Pharmaceutical Co. Ltd. Class A · SSE:603811US$425.5MUS$398.4M15.0×3.2×n/a1.9×22.8%0.0×n/a
Harbin Medisan Pharmaceutical Co., Ltd. Class A · SZSE:002900US$412.2MUS$376.5Mn/a3.0×n/a1.6×−27.1%0.1×n/a
PKU Healthcare Corp. Ltd. Class A · SZSE:000788US$411.5MUS$243.4M133×1.8×n/a1.8×2.3%0.0×n/a
CorMedix Inc. · NASDAQ:CRMDUS$410.8MUS$201.0M6.4×0.5×1.0×0.9×15.5%0.3×0.71
Huaren Pharmaceutical Co., Ltd. Class A · SZSE:300110US$409.0MUS$444.4Mn/a2.4×n/a3.2×−40.2%0.5×n/a
Handa Pharmaceuticals Inc · TPEX:6620US$405.9MUS$292.7M27.3×8.0×15.6×2.7×40.5%0.0×n/a
Zhuhai Rundu Pharmaceutical Co. Ltd. Class A · SZSE:002923US$400.7MUS$380.9M47.1×1.9×n/a2.4×4.2%0.2×n/a
Cheng Du Sheng Nuo Biotec Co., Ltd. Class A · SSE:688117US$397.6MUS$405.9M12.7×2.8×n/a2.3×21.8%0.3×n/a
Kexing Biopharm Co., Ltd. Class A · SSE:688136US$397.2MUS$409.6M35.7×2.1×n/a1.5×5.7%0.4×n/a
Shaanxi Kanghui Pharmaceutical Co. , Ltd. Class A · SSE:603139US$392.2MUS$396.0Mn/a5.1×n/a3.9×−38.4%0.2×n/a
Median of the othersUS$407.4MUS$388.4M27.3×2.6×8.3×2.1×4.9%0.2×0.71

Forecasts

Analysts' consensus from EODHD, read Nov 10, 2026. Not 6ix's view and not investment advice.

Price target
18.00 TWD · Analysts' mean
EPS, year to Dec 2026
0.40 · 1 analyst

Events

QuarterResultsShare move
Q4 2025Mar 5, 2026 · After close+6.7%
Q3 2025Nov 3, 2025 · Before open−0.8%
Q2 2025Aug 5, 2025 · After close−0.8%
Q1 2025May 6, 2025 · After close−0.3%
Q4 2024Feb 25, 2025 · After close−0.7%
Q4 2023Feb 26, 2024 · After close−0.8%
Q3 2023Nov 7, 2023 · After close−5.1%
Q2 2023Aug 7, 2023 · Before open+1.1%
Q1 2023May 10, 2023 · After close−4.5%
Q4 2022Feb 28, 2023 · After close+0.6%
All 18 quarters
QuarterResultsShare move
Q3 2022Nov 8, 2022 · After close+0.6%
Q2 2022Aug 5, 2022 · After close+1.6%
Q1 2022May 6, 2022 · After close−2.5%
Q4 2021Feb 25, 2022 · Before open+1.3%
Quarter to Sep 30, 2021Nov 9, 2021 · After close−0.8%
Quarter to Jun 30, 2021Aug 10, 2021 · After close−0.8%
Quarter to Mar 31, 2021May 10, 2021 · After close−3.0%
Quarter to Dec 31, 2020Mar 18, 2021 · After close−1.0%

Open Events

Decks

DeckKindSlidesDate
H1 2018 Earnings PresentationEarnings23 slidesAug 2, 2018
H1 2018 Earnings PresentationEarnings23 slidesAug 2, 2018
Q4 2017 Earnings PresentationEarnings36 slidesFeb 23, 2018
Q4 2017 Earnings PresentationEarnings36 slidesFeb 23, 2018
JPMorgan Healthcare Conference 2018Conference38 slidesJan 8, 2018
JPM Healthcare Conference 2018Conference38 slidesJan 8, 2018
Investor Presentation (November 2017)Investor deck38 slidesNov 29, 2017
Investor Presentation (November 2017)Investor deck38 slidesNov 29, 2017
2016 JP Morgan Healthcare ConferenceConference25 slidesJan 14, 2016
Investor Presentation (October 2015)Investor deck27 slidesOct 8, 2015
All 45 decks
DeckKindSlidesDate
Fact Sheet (2014)Fact sheet3 slidesSep 15, 2014
Q1 2014 Earnings PresentationEarnings32 slidesMay 9, 2014
Q1 2014 Earnings PresentationEarnings32 slidesMay 9, 2014
Investor Presentation (April 2014)Investor deck23 slidesApr 9, 2014
FY2013 Earnings PresentationEarnings23 slidesApr 9, 2014
Investor Presentation (March 2014)Investor deck33 slidesMar 24, 2014
Investor Presentation (March 2014)Investor deck30 slidesMar 24, 2014
Investor Presentation (February 2014)Investor deck23 slidesFeb 14, 2014
Investor Presentation (November 2013)Investor deck26 slidesNov 12, 2013
Q3 2013 Earnings PresentationEarnings26 slidesNov 12, 2013
Q2 2013 Earnings PresentationEarnings32 slidesSeptember 2013
Q2 2013 Earnings PresentationEarnings31 slidesAug 7, 2013
Q2 2013 Earnings PresentationEarnings31 slidesAug 7, 2013
Q1 2013 Earnings PresentationEarnings24 slidesMay 10, 2013
Q1 2013 Earnings PresentationEarnings33 slidesMay 2013
FY2012 Earnings PresentationEarnings35 slidesMar 27, 2013
FY2012 Earnings PresentationEarnings35 slidesJan 30, 2013
Investor Presentation (January 2013)Investor deck37 slidesJan 9, 2013
Investor Presentation (January 2013)Investor deck38 slidesJanuary 2013
Investor Presentation (January 2013)Investor deck35 slidesJanuary 2013
Investor Presentation (October 2012)Investor deck37 slidesOct 29, 2012
DB Conference 2012Conference26 slidesAug 31, 2012
1H 2012 Earnings PresentationEarnings36 slidesAug 23, 2012
Investor Presentation (August 2012)Investor deck35 slidesAug 23, 2012
Q1 2012 Earnings PresentationEarnings28 slidesJul 10, 2012
Q1 2012 Earnings PresentationEarnings26 slidesJuly 2012
Citi Conference 2012Conference26 slidesMay 8, 2012
Investor Presentation (April 2012)Investor deck36 slidesApr 18, 2012
Investor Presentation (April 2012)Investor deck37 slidesApr 18, 2012
Investor Presentation (March 2012)Investor deck31 slidesMar 14, 2012
Investor Presentation (March 2012)Investor deck27 slidesMar 14, 2012
J.P. Morgan Healthcare Conference 2012Conference25 slidesJan 12, 2012
J.P. Morgan Healthcare Conference 2012Conference28 slidesJan 9, 2012
Q3 2011 Earnings PresentationEarnings31 slidesNovember 2011
IPO Roadshow (September 2011)IPO roadshow41 slidesSeptember 2011

Open Decks

Financials

Annual, in TWD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue3.16B3.41B3.19B3.26B2.76B3.08B2.89B3.52B3.52B4.03B
Cost of revenue2.07B2.11B1.97B2.01B1.48B1.77B1.72B1.98B1.97B2.22B
Gross profit1.10B1.30B1.22B1.25B1.28B1.32B1.18B1.54B1.55B1.81B
Research and development497.3M459.4M357.7M271.3M306.0M245.6M238.4M313.2M314.3M279.6M
Selling, general and administrative363.2M376.4M364.2M406.5M532.2M525.4M513.8M524.0M531.2M488.1M
Operating income108.9M322.7M314.5M405.6M288.7M375.5M267.1M558.3M559.0M868.3M
Depreciation and amortization516.7M488.3M461.2M439.5M381.5M393.2M408.7M405.8M432.5M444.8M
EBITDA625.6M811.0M775.7M845.1M670.3M768.7M675.8M964.1M991.5M1.31B
Interest expense9.87M8.08M9.15M7.91M6.55M15.2M55.7M80.2M76.6M36.1M
Income before tax147.4M413.0M348.8M438.0M302.3M358.5M265.1M490.5M475.3M810.6M
Income tax10.4M73.7M61.8M84.7M58.8M76.4M48.4M47.6M52.9M151.9M
Net income137.0M339.4M287.1M353.2M243.5M282.1M216.7M443.0M422.4M658.7M
Earnings per share, basic0.170.430.360.450.310.360.270.560.530.83

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents3.11B4.17B3.94B4.29B4.08B4.05B3.30B4.20B3.91B3.71B
Short-term investments90.0K8.30M51.1M50.7M34.3M175.1M179.0M443.3M417.0M
Receivables624.0M654.2M779.9M653.5M393.0M472.9M670.5M663.0M764.9M836.3M
Inventory1.64B1.67B1.51B1.19B1.35B1.25B1.12B1.36B1.68B1.83B
Current assets5.49B6.61B6.38B6.32B5.97B5.92B5.41B6.51B6.47B6.59B
Property, plant and equipment4.50B4.65B4.84B5.11B4.76B5.09B5.21B
Total assets11.9B11.9B11.7B11.9B11.7B11.8B11.7B12.6B12.7B12.8B
Accounts payable62.5M81.0M101.3M125.3M69.7M159.7M101.0M89.4M90.8M69.7M
Current liabilities709.8M767.7M729.5M803.1M556.3M686.6M741.7M1.95B1.12B1.69B
Long-term debt01.10B770.9M
Total debt762.7M676.8M621.1M677.9M557.6M577.3M697.2M1.41B1.69B1.79B
Total liabilities1.33B1.42B1.36B1.46B1.18B1.32B1.41B2.02B2.28B2.56B
Shareholders' equity10.5B10.5B10.4B10.5B10.5B10.5B10.3B10.5B10.4B10.2B
Shares outstanding805.6M792.9M792.3M792.7M792.3M792.2M792.1M793.1M792.6M793.7M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations597.1M750.9M231.1M773.8M509.8M946.3M788.9M1.23B971.7M1.67B
Capital spending-291.3M-288.7M-284.7M-250.0M-321.3M-183.1M-105.7M-127.0M-410.9M-458.5M
Free cash flow305.8M462.2M-53.6M523.7M188.5M763.2M683.2M1.10B560.8M1.21B
Cash from investing-1.45B-293.4M-233.3M-253.6M-70.0M241.7M-98.4M-300.0M-437.3M-202.3M
Cash from financing-203.5M-244.9M-341.0M-314.8M-412.8M-444.9M-1.57B-627.0M-313.9M-137.6M
Dividends paid-276.8M-237.2M-284.7M-379.6M-395.4M-213.5M-387.5M-379.6M-228.1M-219.3M
Change in cash-1.06B224.5M-353.2M213.8M26.0M750.0M-898.4M292.5M203.6M1.37B

Open Financials

Cap table

Built by 6ix from ScinoPharm Taiwan, Ltd.’s releases

Common shares
790,739,000
Fully diluted
790,739,000

Fully diluted

LineShares
Common shares790,739,000

Share count over time

CountShares
Nov 22, 2026790,739,000

Open Cap table

Shareholders

Register

HolderSharesOf the companyAs of
統一企業股份有限公司300M37.9%Oct 31, 2026
行政院國家發展基金管理會110M13.9%Oct 31, 2026
台灣糖業股份有限公司32.6M4.1%Oct 31, 2026
統一國際開發股份有限公司28.7M3.6%Oct 31, 2026
臺南紡織股份有限公司23.6M3.0%Oct 31, 2026
高權投資股份有限公司14.8M1.9%Oct 31, 2026
洪玉芬102K0.01%Oct 31, 2026
沈育維60,000<0.01%Oct 31, 2026
林祺晶33,512<0.01%Oct 31, 2026
陳惠君10,000<0.01%Oct 31, 2026
All 47 holders
HolderSharesOf the companyAs of
劉顯斌5,922<0.01%Oct 31, 2026
陳嘉真4,326<0.01%Oct 31, 2026
李丁讚2,458<0.01%Oct 31, 2026
王耀輝154<0.01%Oct 31, 2026
蔡成志153<0.01%Oct 31, 2026
張俐巧8<0.01%Oct 31, 2026
蘇來守00.00%Oct 31, 2026
郭嘉宏00.00%Oct 31, 2026
楊士豪00.00%Oct 31, 2026
侯博明00.00%Oct 31, 2026
李明憲00.00%Oct 31, 2026
張俊彥00.00%Oct 31, 2026
吳琮斌00.00%Oct 31, 2026
王惠鈴00.00%Oct 31, 2026
楊俊佑00.00%Oct 31, 2026
王佳蕙00.00%Oct 31, 2026
謝明娟00.00%Oct 31, 2026
陳立宗00.00%Oct 31, 2026
楊雅博00.00%Oct 31, 2026
賴富榮00.00%Oct 31, 2026
許明雄00.00%Oct 31, 2026
蔡勇志00.00%Oct 31, 2026
張正平00.00%Oct 31, 2026
張文昌00.00%Oct 31, 2026
羅智先00.00%Oct 31, 2026
盧麗安00.00%Oct 31, 2026
施秋茹00.00%Oct 31, 2026
王彥超00.00%Oct 31, 2026
溫斯瑞00.00%Oct 31, 2026
孫鈴明00.00%Sep 30, 2026
周世明00.00%Oct 31, 2026
蘇昌輝00.00%Oct 31, 2026
高秀玲00.00%Oct 31, 2026
簡誌緯00.00%Oct 31, 2026
連凌霄00.00%Oct 31, 2026
行政院國家發展基金管理會Nov 21, 2026
統一企業股份有限公司Nov 21, 2026

Open Shareholders

Log in to ask 6ix AI your own questions about ScinoPharm Taiwan, Ltd.